Association Between IGF2BP2 rs4402960 Polymorphism and Risk of Type 2 Diabetes Mellitus: A Meta-analysis

Archives of Medical Research

Volumn 42, Issue 5, 2011, Pages 361-367

  Jia, Hongxia ^a   Yu, Lili ^c   Jiang, Zhiwei ^b   Ji, Qiuhe ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Association; IGF2BP2; Meta analysis; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 2;

ALLELE; ARTICLE; CONTROLLED STUDY; EFFECT SIZE; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RNA-BINDING PROTEINS;

EID: 80052717125     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.08.001     Document Type: Article

References (46)

1. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
3. Jin W., Patti M.E. Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes. Clin Sci (Lond) 2009, 116:99-111.
4. Permutt M.A., Wasson J., Cox N. Genetic epidemiology of diabetes. J Clin Invest 2005, 115:1431-1439.
5. Christiansen J., Kolte A.M., Hansen T.O., et al. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol 2009, 43:187-195.
6. Nielsen J., Christiansen J., Lykke-Andersen J., et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999, 19:1262-1270.
7. Grarup N., Rose C.S., Andersson E.A., et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 2007, 56:3105-3111.
8. Groenewoud M.J., Dekker J.M., Fritsche A., et al. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 2008, 51:1659-1663.
9. Lyssenko V., Jonsson A., Almgren P., et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008, 359:2220-2232.
10. Palmer N.D., Goodarzi M.O., Langefeld C.D., et al. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes 2008, 57:1093-1100.
11. Rodriguez S., Eiriksdottir G., Gaunt T.R., et al. IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes. Growth Horm IGF Res 2010, 20:310-318.
12. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
13. Scott L.J., Mohlke K.L., Bonnycastle L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
14. Zeggini E., Weedon M.N., Lindgren C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
15. Takeuchi F., Serizawa M., Yamamoto K., et al. Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009, 58:1690-1699.
16. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
17. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
18. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
19. Lewis J.P., Palmer N.D., Hicks P.J., et al. Association analysis in African Americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes 2008, 57:2220-2225.
20. Horikoshi M., Hara K., Ito C., et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 2007, 50:2461-2466.
21. Wu Y., Li H., Loos R.J., et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008, 57:2834-2842.
22. Ng M.C., Park K.S., Oh B., et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 2008, 57:2226-2233.
23. Duesing K., Fatemifar G., Charpentier G., et al. Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians. Diabetes 2008, 57:1992-1996.
24. Sanghera D.K., Ortega L., Han S., et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet 2008, 9:59-67.
25. Hertel J.K., Johansson S., Raeder H., et al. Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia 2008, 51:971-977.
26. Liu Y., Yu L., Zhang D., et al. Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia 2008, 51:2134-2137.
27. Bronstein M., Pisante A., Yakir B., et al. Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population. Hum Genet 2008, 124:101-104.
28. Horikawa Y., Miyake K., Yasuda K., et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 2008, 93:3136-3141.
29. Lee Y.H., Kang E.S., Kim S.H., et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet 2008, 53:991-998.
30. Omori S., Tanaka Y., Takahashi A., et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008, 57:791-795.
31. Herder C., Rathmann W., Strassburger K., et al. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Horm Metab Res 2008, 40:722-726.
32. Cauchi S., Meyre D., Durand E., et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 2008, 3:e2031.
33. van Hoek M., Dehghan A., Witteman J.C., et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 2008, 57:3122-3128.
34. Rong R., Hanson R.L., Ortiz D., et al. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 2009, 58:478-488.
35. Tabara Y., Osawa H., Kawamoto R., et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 2009, 58:493-498.
36. Tan J.T., Ng D.P., Nurbaya S., et al. Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J Clin Endocrinol Metab 2010, 95:390-397.
37. Han X., Luo Y., Ren Q., et al. Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population. BMC Med Genet 2010, 11:81-89.
38. Huang Q., Yin J.Y., Dai X.P., et al. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Acta Pharmacol Sin 2010, 31:709-717.
39. Wen J., Ronn T., Olsson A., et al. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One 2010, 5. e9153.
40. Chauhan G., Spurgeon C.J., Tabassum R., et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes 2010, 59:2068-2074.
41. Rees S.D., Hydrie M.Z., Shera A.S., et al. Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia 2011, 54:1368-1374.
42. Salanti G., Southam L., Altshuler D., et al. Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol 2009, 170:537-545.
43. Wagner M., Kunsch S., Duerschmied D., et al. Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas. Gastroenterology 2003, 124:1901-1914.
44. Stancakova A., Kuulasmaa T., Paananen J., et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes 2009, 58:2129-2136.
45. Webster R.J., Warrington N.M., Beilby J.P., et al. The longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI. BMC Med Genet 2010, 11:140-149.
46. Doria A., Patti M.E., Kahn C.R. The emerging genetic architecture of type 2 diabetes. Cell Metab 2008, 8:186-200.